Challenges for NHS hospitals during covid-19 epidemic

Abstract

Delivery of every aspect of care by all clinical and non-clinical departments in the UK's NHS is being reassessed and fundamentally reorganised in the expectation of an imminent surge of patients with covid-19. 1 Modelling of the outbreak assumes an infection fatality ratio of 0.9% and a hospital admission rate of 4.4%, with 30% of those admitted requiring critical care or extracorporeal membrane oxygenation. 2 3 The increased demand on healthcare services will be compounded by the apparent increased risk of infection among healthcare workers, 4 and staff absences because of illness or self-isolation may be as high as 20%. 11 The government has made recommendations for case isolation, social distancing, and household quarantine intended to reduce the peak of the epidemic and the resulting pressure on NHS hospitals. 5 6

WITHDRAWN: Community pharmacists: On the frontline of health service against COVID-19 in LMICs

“…Covid-19 was recognized in December 2019. 1 The impact on every level of society has been profound and, over the coming weeks and months, the challenges faced by healthcare services will be compounded by the increased risk of infection among healthcare workers and ensuing staff absences due to illness or the need to self-isolate 3 . In the face of public health emergencies, domestic and foreign clinical pharmacists collaborated together to take advantage of their pharmacology and therapeutics expertise to actively participate in the medical activities of COVID-19, and to maximize pharmacists' value and responsibility.…”

Community Pharmacists: On the frontline of health service against COVID-19 in LMICs

“…1 The impact on every level of society has been profound and, over the coming weeks and months, the challenges faced by healthcare services will be compounded by the increased risk of infection among healthcare workers and ensuing staff absences due to illness or the need to selfisolate. 2 In the face of public health emergencies, domestic and foreign clinical pharmacists collaborated together to take advantage of their pharmacology and therapeutics expertise to actively participate in the medical activities of COVID-19, and to maximize pharmacists' value and responsibility. 30 In many communities, pharmacists are the most accessible healthcare providers and the first touch point of patient engagement with the healthcare system.…”

How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation

“…3 Multiple reports of a shortage of medical equipment, hospital and intensive care unit (ICU) beds have been published and impose difficult ethical choices on the medical community. 4 Cancer patients might be impacted by the overuse of medical resources and it may affect their treatment, as well as their follow-up. Multiple medical societies have published general guidelines regarding cancer care during times of medical overuse, including guidelines for the management of hematological patients 5 and bone marrow transplantation.…”